In the latest episode of the “European Health Union Now!” podcast, ECDC Director Andrea Ammon discusses a strengthened and potentially extended mandate for ECDC with Dorli-Kahr Gottlieb, Secretary General of the European Health Forum Gastein.
Threat Assessment Brief: Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA
The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2.
Europe Day, celebrated each year on 9 May, marks the anniversary of the Schuman Declaration.
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
This document assesses the risk related to dengue for EU/EEA citizens travelling to or residing in Réunion, and the risk related to having an outbreak of dengue in mainland EU/EEA following introduction of the virus from Réunion.
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization to mobilise people around the world to increase adherence to hand hygiene in all healthcare settings, thus protecting healthcare workers and patients from healthcare-associated infections caused by various pathogens.
Since the discovery of SARS-CoV-2, three variants of concern (VOC), first identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1), have been associated with higher transmissibility and severity of disease, with potential implications for acquired immunity or the effectiveness of current vaccines.
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) today kicked off a new initiative aimed at strengthening post-marketing monitoring of the safety, effectiveness and impact of COVID-19 vaccines in the EU/EEA.
European Immunization Week (EIW) is marked across the European Region every year in the last week of April. It aims to raise awareness of the importance of immunisation for people’s health and well-being.
Europe is at a critical juncture in its fight against COVID-19. Many countries are currently relaxing restrictions, some against a backdrop of increasing numbers of cases and with new variants emerging, while still rolling out nationwide vaccination programmes.
Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions.
ECDC organises the first of many capacity building activities to be provided to EU neighbouring countries as part of the new EU Initiative on Health Security.
Postcard from the field: A ‘Field Mission’ from my living room - supporting the WHO epidemiology team during the 11th Ebola outbreak in the Democratic Republic of Congo
By September 2020 there was no more denying that we, the fellows of 2019, would be the ‘pandemic cohort’ - or at least one of them for all we knew.
ECDC invites experts to express their interest to contribute to strengthening Africa CDC capacities in preparedness, surveillance, and response to health threats posed by communicable diseases.
A sizeable proportion of Salmonella and Campylobacter bacteria is still resistant to antibiotics commonly used in humans and animals, as in previous years, says a report released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
Postcard from the field: Responding to the Ebola outbreak in Equateur Province, Democratic Republic of the Congo
In August 2020, Global Outbreak and Alert and Response Network (GOARN) sent a request for assistance for epidemiologists to be deployed to the Democratic Republic of the Congo (DRC) to support the Ebola virus disease (EVD) outbreak response in the Equateur Province.
In the Technical Report Risk for SARS-CoV-2 transmission from newly infected individuals with documented previous infection or vaccination, published today, ECDC examines the evidence on the extent previous SARS-CoV-2 infection or COVID-19 vaccination prevents onward transmission from infected individuals to susceptible contacts.
Pioneering project describes molecular epidemiology of listeriosis in humans and Listeria monocytogenes in food
A collaborative study between ECDC, the European Food Safety Authority (EFSA) and the European Union Reference Laboratory (EURL) for Listeria monocytogenes* found a relatively high degree of dissemination of certain listeriosis bacteria in the food chain and in the human population across the European Union (EU).
The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and is down 19% overall for 2015–2019, according to the latest WHO/European Centre for Disease Prevention and Control (ECDC) report Tuberculosis surveillance and monitoring in Europe 2021 (2019 data).
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).